Barchart on Facebook
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Milestone Scientific (MLSS)

Milestone Scientific (MLSS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 112,581
  • Shares Outstanding, K 63,605
  • Annual Sales, $ 8,370 K
  • Annual Income, $ -7,520 K
  • 60-Month Beta 1.46
  • Price/Sales 12.83
  • Price/Cash Flow N/A
  • Price/Book 5.52
Trade MLSS with:

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/20
See More
  • Average Estimate -0.05
  • Number of Estimates 1
  • High Estimate -0.05
  • Low Estimate -0.05
  • Prior Year -0.06
  • Growth Rate Est. (year over year) +16.67%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.3600 +22.06%
on 10/01/20
2.1700 -23.50%
on 10/13/20
+0.2600 (+18.57%)
since 09/25/20
3-Month
1.3000 +27.69%
on 09/25/20
2.1700 -23.50%
on 10/13/20
-0.0800 (-4.60%)
since 07/24/20
52-Week
0.8500 +95.29%
on 04/07/20
3.0450 -45.48%
on 06/22/20
+0.6100 (+58.10%)
since 10/25/19

Most Recent Stories

More News
Milestone Scientific Inc. Publishes Video Interview with Dr. Ayman A. Alian, Division Chief of Obstetric & Gynecological Anesthesiology at Yale School of Medicine

Milestone Scientific Inc. (NYSE American:MLSS), a leading developer of computerized drug delivery instruments that provides virtually painless and precise injections, reports it has published a video interview...

MLSS : 1.6600 (-6.21%)
Milestone Scientific Inc. Awarded Group Purchasing Agreement with Premier for CompuFlo(R) Epidural System and CathCheck(TM)

Milestone Scientific Inc. (NYSE American:MLSS), a leading developer of computerized drug delivery instruments that provide virtually painless and precise injections, today announced that it has been awarded...

MLSS : 1.6600 (-6.21%)
The MicroCap Rodeo Best Ideas Bowl 2020; October 13-16, 2020

The MicroCap Rodeo continues this year with its first virtual event set for October 13-16, 2020. This year' "Best Ideas" conference focuses solely on 25 public companies recommended by institutional investors...

AWH : 3.60 (-2.17%)
ARHH : 0.7452 (-1.99%)
CSSE : 14.48 (-1.36%)
DXR : 14.67 (-0.41%)
DRAD : 2.80 (-6.67%)
ECOR : 1.6100 (-3.59%)
ISDR : 20.78 (-0.62%)
LMPX : 24.81 (-6.69%)
MDP.VN : 4.420 (+1.14%)
MLSS : 1.6600 (-6.21%)
MIND : 2.24 (-3.03%)
MYO : 4.55 (-0.66%)
NEPH : 6.50 (-5.52%)
PFSW : 6.65 (-5.41%)
SSKN : 1.3500 (-3.57%)
STRM : 1.3500 (-4.58%)
TTI : 0.5600 (-4.26%)
THBRF : 1.6000 (+0.63%)
Milestone Scientific to Present at MicroCap Rodeo Best Ideas Bowl on October 13th

ROSELAND, NJ / ACCESSWIRE / October 7, 2020 / Milestone Scientific Inc. (NYSE American:MLSS), a leading developer of computerized drug instruments that provide painless and precise injections, today announced...

MLSS : 1.6600 (-6.21%)
Milestone Scientific Inc. Projects Over Five-Fold Sequential Increase in Dental Sales for Q3 2020 Versus Q2 2020

Milestone Scientific Inc. (NYSE American: MLSS), a leading developer of computerized drug delivery instruments that provides painless and precise injections, today announced that it projects sales for...

MLSS : 1.6600 (-6.21%)
Milestone Scientific to Hold Investor Webinar and Q&A Session with CEO on September 14

ROSELAND, NJ / ACCESSWIRE / September 10, 2020 / Milestone Scientific Inc. (NYSE American:MLSS), a leading developer of computerized drug delivery instruments that provides painless and precise injections,...

MLSS : 1.6600 (-6.21%)
Milestone Scientific Reports Increasing Dental Sales and Robust Pipeline for CompuFlo(R) Epidural System and CathCheck(TM)

Anticipates Q3 2020 dental revenue to increase at least four-fold versus Q2 2020

MLSS : 1.6600 (-6.21%)
Milestone Scientific Promotes Arjan Haverhals to President of Milestone Scientific

ROSELAND, NJ / ACCESSWIRE / September 1, 2020 / Milestone Scientific Inc. (NYSE American:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections,...

MLSS : 1.6600 (-6.21%)
Milestone Scientific to Present at The LD 500 Virtual Conference on September 1st

ROSELAND, NJ / ACCESSWIRE / August 27, 2020 / Milestone Scientific Inc. (NYSE American:MLSS), a leading developer of computerized drug instruments that provide painless and precise injections, today announced...

MLSS : 1.6600 (-6.21%)
Milestone Scientific Provides Business Update and Reports Financial Results for the Second Quarter of 2020

, a leading developer of computerized drug delivery instruments that provide painless and precise injections, today provided a business update and announced financial results for the second quarter and...

MLSS : 1.6600 (-6.21%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Sell with a Average short term outlook on maintaining the current direction.

See More Share

Business Summary

Milestone Scientific, Inc. develops, manufactures, markets and sells equipment and related disposable or consumable items and other products for use primarily by the dental practitioner. The company's principal product is ``The Wand(TM)``, a computer controlled ``painless`` injection system enabling...

See More

Key Turning Points

2nd Resistance Point 1.8067
1st Resistance Point 1.7333
Last Price 1.6600
1st Support Level 1.6133
2nd Support Level 1.5667

See More

52-Week High 3.0450
Fibonacci 61.8% 2.2065
Fibonacci 50% 1.9475
Fibonacci 38.2% 1.6885
Last Price 1.6600
52-Week Low 0.8500

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar